Compare Heron Therapeutics Inc (HRTX) vs Vanguard Global ex-US Real Estate Index Fd ETF (VNQI) Price & Performance

HRTX trades at $0.3507, up 6.21% in the last 24 hours, but technical indicators signal a bearish trend overall. The company reported Q2 2026 revenue of $37.7 million, missing estimates, with a net loss per share of $0.03. Despite a high gross profit margin of 70.07%, negative net income and cash flow from operations highlight financial strain. Analyst consensus remains strongly bullish with 94.74% buy ratings, but recent news includes a Zacks Strong Sell designation on July 15, 2026.

The outlook is mixed: strong analyst support contrasts with weak earnings and bearish technicals. Investment opportunity lies in potential turnaround if revenue growth accelerates, but risks include persistent losses, competitive pressures, and reliance on financing activities. The stock faces significant downside if operational performance does not improve.

VNQI (Vanguard Global ex-U.S. Real Estate ETF) trades at $45.72, up 0.35% with a bullish technical signal from moving averages. The ETF provides diversified international real estate exposure across 30+ countries outside the U.S. with a competitive expense ratio and higher dividend yield compared to domestic REIT ETFs. Recent institutional activity shows Balefire LLC reduced its position by 78.7% in Q2 2026.

The fund offers international real estate diversification benefits but faces currency risk and potential underperformance versus U.S. REITs. Current technical momentum supports near-term upside, though investors should weigh the trade-off between higher yield and historical total return lag against domestic alternatives.